Reinforcing effects of certain serotonin-releasing amphetamine derivatives

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 99-105

  Marona Lewicka, Danuta ^a   Rhee, Gyu Seek ^a   Sprague, Jon E ^a   Nichols, David E ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Conditioned place preference; Dopamine; Fenfluramine; In vivo microdialysis in freely moving rats; MBDB; MDMA; MMAI; Nucleus accumbens; Place aversion; Reward

Indexed keywords

1 (1,3 BENZODIOXOL 5 YL) N METHYL 2 BUTANAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 METHOXY 6 METHYL 2 AMINOINDAN; AMPHETAMINE DERIVATIVE; DOPAMINE; FENFLURAMINE; SEROTONIN RELEASING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD;

EID: 0029877397     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00205-7     Document Type: Article

References (84)

1. Aigner, T. G.; Balster, R. L. Rapid substitution for intravenous self-stimulation studies in rhesus monkeys. Pharmacol. Biochem. Behav. 10:105-112; 1979.
2. Anderson, G. M. III; Braun, G.; Graun, U.; Nichols, D. E.; Shulgin, A. T. Absolute configuration and psychomimetic activity. In: Barnett, G.; Trsic M.; Willette M. E., eds. NIDA Research Monograph, vol. 22. QuaSAR Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. Washington, D.C.: U.S. Government Printing Office; 1978:27-32.
3. Appel, N. M.; Contrera, J. F.; De Souza, E. B. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: Evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther. 249:928-943; 1989.
4. Battaglia, G.; Yeh, S. Y.; De Souza, E. B. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 29:269-274; 1988.
5. Beardsley, P. M.; Balster, R. L.; Harris, L. S. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend. 18:149-157; 1986.
6. Bilsky, E. J.; Hubbell, C. L.; Deloconte, J. D.; Reid, L. D. MDMA produces a conditioned place preference and elicits ejaculation in male rats: A modulatory role for the endogenous opioids. Pharmacol. Biochem. Behav. 40:443-447; 1991.
7. Bilsky, E. J.; Hui, Y.; Hubbell, C. L.; Reid, L. D. Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage. Pharmacol. Biochem. Behav. 37:633-638; 1990.
8. 3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 39:509-512; 1991.
9. Booth, D. A.; Pilcher, C. W.; D'Mello, G. D.; Stolerman, I. P. Comparative potencies of amphetamine, fenfluramine and related compounds in taste aversion experiments in rats. Br. J. Pharmacol. 61:669-677; 1977.
10. Caccia, S.; Anelli, M.; Ferrarese, A.; Fracasso, C.; Garattini, S. Single- and multiple-dose kinetics of D-fenfluramine in rats given anorectic and toxic doses. Xenobiotica 22:217-226; 1992.
11. Callaway, C. W.; Johnson, M. P.; Gold, L. H.; Nichols, D. E.; Geyer, M. A. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology 104:293-301; 1991.
12. Callaway, C. W.; Wing, L. L.; Nichols, D. E.; Geyer, M. A. Suppression of behavioral activity by norfenfluramine and related drugs is not mediated by serotonin release. Psychopharmacology 111:169-182; 1993.
13. Carr, G. D.; Fibiger, H. C.; Phillips, A. G. Conditioned place preference as a measure of drug reward. In: Liebman, J. M.; Cooper, S. J., eds. In: The neuropharmacological basis of reward. Oxford, UK: Oxford University Press; 1989:264-319.
14. Carr, G. D.; Phillips, A. G.; Fibiger, H. C. Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference. Psychopharmacology 94:221-226; 1988.
15. Carr, G. D.; White, N. M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33:2551-2557; 1983.
16. Carr, G. D.; White, N. M. Anatomical dissociation of amphetamine's rewarding and aversive effects: An intracranial microinjection study. Psychopharmacology 89:340-346; 1986.
17. Climko, R. P.; Roehrich, H.; Sweeney, D. R.; Al-Razi, J. Ecstasy: A review of MDMA and MDA. Int. J. Psychiatry Med. 16: 359-372; 1987.
18. Commins, D. L.; Vosmer, G.; Virus, R. M.; Woolverton, W. L.; Schuster, C. R.; Seiden, L. S. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Ther. 241:338-345; 1987.
19. Costa, E.; Gropetti, A.; Revuelta, A. Action of fenfluramine on monoamine stores of rat tissues. Br. J. Pharmacol. 41:57-64; 1971.
20. 3 receptor antagonist GR 38032F on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol. 92:881-890; 1987.
21. Davies, A. M.; Parker, L. A. Fenfluramine-induced place aversion in a three-choice apparatus. Pharmacol. Biochem. Behav. 44:595-600; 1993.
22. 3H]-serotonin. Naunyn-Schmied. Arch. Pharmacol. 345:1-6; 1992.
23. Fletcher, P. J.; Burton, M. J. Effects of manipulations of peripheral serotonin on feeding and drinking in the rat. Pharmacol. Biochem. Behav. 20:835-840; 1984.
24. Glennon, R. A.; Yousif, M.; Patrick, G. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav. 29:443-449; 1988.
25. Glowa, J. R.; Wojnicki, F. H. E.; Rothman, R. B. Effects of phentermine, fenfluramine and both in combination on food- and cocaine-maintained responding of rhesus monkeys. Abstr. Soc. Neurosci. 20:222; 1994.
26. Gotestam, K. G.; Andersson, B. E. Self-administration of amphetamine analogues in rats. Pharmacol. Biochem. Behav. 3:229-233; 1975.
27. Goudie, A. J.; Taylor, M.; Atherton, H. Effects of prior drug experience on the establishment of taste aversion in rats. Pharmacol. Biochem. Behav. 3:947-952; 1975.
28. Goudie, A. J.; Thornton, E. W.; Wheeler, T. J. Drug pretreatment effects in drug induced taste aversion: Effects of dose and duration of pretreatment. Pharmacol. Biochem. Behav. 4:629-633; 1976.
29. Griffiths, R. R.; Brady, J. V.; Snell, J. D. Progressive-ratio performance maintained by drug infusion: Comparison of cocaine, diethylpropion, chlorophenetermine, and fenfluramine. Psychopharmacology (Berlin) 50:251-258; 1976.
30. Gysling, K.; Wang, R. Y. Morphine-induced activation of A-10 dopamine neurons in the rat. Brain Res. 277:119-127; 1983.
31. Hiromatsu, H.; Cho, A. K. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely moving rats: An in vivo microdialysis study. Neuropharmacology 29:269-275; 1990.
32. Hiromatsu, H.; DiStefano, E.; Chang, A. S.; Cho, A. K. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in rat brain dialysates. Eur. J. Pharmacol. 204:135-140; 1991.
33. Hubner, C. B.; Brid, M.; Rassnick, S.; Kornetsky, C. The threshold lowering effects of MDMA (ecstasy) on brain stimulation reward. Psychopharmacology (Berlin) 95:49-51; 1988.
34. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 101:214-218; 1989.
35. Invernizzi, R.; Berettera C.; Garattini, S.; Samanin, R. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur. J. Pharmacot. 120:9-15; 1986.
36. Johnson, M.; Letter, A. A.; Merchant, K.; Hanson, G. R.; Gibb, J. W. Effects of 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. J. Pharmacol. Exp. Ther. 244:977-989; 1988.
37. 3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Eur. J. Pharmacol. 200:9-16; 1991.
38. Johnson, M. P.; Frescas, S. P.; Oberlender, R.; Nichols, D. E. Synthesis and pharmacological examination of 1-(3-methoxy-4-methyl-phenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: Similarities to 3,4-(methylenedioxy)-methamphetamine (MDMA). J. Med. Chem. 34:1662-1668; 1991.
39. 3H]-dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132:269-276; 1986.
40. Johnson, M. P.; Nichols, D. E. Neurotoxic effects of the alphaethyl homologue of MDMA following subacute administration. Pharmacol. Biochem. Behav. 33:105-108; 1989.
41. Johnson, M. P.; Nichols, D. E. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav. 36:105-109; 1990.
42. Kalia, M. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons. Brain Res. 548:111-125; 1991.
43. Kleven, M. S.; Schuster, C. R.; Seiden, L. S. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther. 246:822-828; 1988.
44. Koob, G. F. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-184; 1992.
45. Kornblith, C. L.; Hoebel, B. G. A dose-response study of anorectic drug effects on food intake, self-stimulation and stimulation-escape. Pharmacot. Biochem. Behav. 5:215-218; 1976.
46. Kruszewska, A.; Romandini, S.; Samanin, R. Different effects of zimelidine on the reinforcing properties of D-amphetamine and morphine on conditioned place preference in rats. Eur. J. Pharmacol. 125:283-286; 1986.
47. Lamb, R.; Griffiths, R. Self-injections of d-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology (Berlin) 91:268-272; 1987.
48. Lyness, W. Y.; Friedle, N. M.; Moore, K. E. Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on D-amphetamine self-administration. Pharmacol. Biochem. Behav. 11:553-556; 1979.
49. Marona-Lewicka, D.; Nichols, D. E. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Eur. J. Pharmacol. 258:1-13; 1994.
50. McTavish, D.; Heel, R. C. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. Drugs 43:713-733; 1992.
51. Molliver, D. C.; Molliver, M. E. Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat. Brain Res. 511:165-168; 1990.
52. Nash, J. F.; Brodkin, J. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: Effect of dopamine uptake inhibitors. J. Pharmacol. Exp. Ther. 259:820-825; 1991.
53. Nash, J. F.; Nichols, D. E. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Eur. J. Pharmacol. 200:53-58; 1991.
54. Nichols, D. E. Differences between the mechanisms of action of MDMA, MBDB, and the classical hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18:305-313; 1986.
55. 3H]-serotonin from rat brain synaptosomes. J. Med. Chem. 25:530-535; 1982.
56. Nichols, D. E.; Marona-Lewicka, D.; Huang, X.; Johnson, M. P. Novel serotonergic agents. Drug Des. Discov. 9:299-312; 1993.
57. Nichols, D. E.; Oberlender, R. Structure-activity relationships of MDMA and related compounds: A new class of psychoactive agents? In: Peroutka, S. J., ed. Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA. Boston: Kluwer Academic; 1990:53-62.
58. Nomikos, G. G.; Spyraki, C. Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats. Pharmacol. Biochem. Behav. 30:853-858; 1988.
59. Oberlender, R.; Nichols, D. E. (+)-N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxymethamphetamine-like behavioral activity. J. Pharmacol. Exp. Ther. 255:1098-1106; 1990.
60. O'Hearn, E.; Battaglia, G.; De Souza, E. B.; Kuhar, M. J.; Molliver, M. E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in the forebrain: Immunocytochemical evidence for neurotoxicity. J. Neurosci. 8:2788-2830; 1988.
61. Pellegrino, L. J.; Pellegrino, A. S.; Cushman, A. C. A stereotaxic atlas of the rat brain. New York: Plenum Press; 1979.
62. Peroutka, S. J. Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy") on an undergraduate campus. N. Engl. J. Med. 317:1542-1543:1987.
63. Peroutka, S. J. Recreational use of MDMA. In: Peroutka, S. J., ed. Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA. Boston: Kluwer Academic; 1990:53-62.
64. Peroutka, S. J.; Newman, H.; Harris, H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273-277; 1988.
65. Risner, M. E.; Silcox, D. L. Psychostimulant self-administration by beagle dogs in a progressive-ratio paradigm. Psychopharmacology (Berlin) 75:25-30; 1981.
66. Schaechter, J. D.; Wurtman, R. J. Effect of chronic D-fenfluramine administration on rat hypothalamic serotonin levels and release. Life Sci. 44:265-271; 1989.
67. Schechter, M. D. Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Biochem. Behav. 31:817-824; 1989.
68. Schechter, M. D. Functional consequences of fenfluramine neurotoxicity. Pharmacol. Biochem. Behav. 37:623-626; 1990.
69. Schechter, M. D. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacology. Biochem. Behav. 38:539-544; 1991.
70. Schmidt, C. J. Neurotoxicity of the psychedelic amphetamine methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240:1-7; 1987.
71. Schmidt, C. J.; Levin, J. A.; Lovenberg, W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in rat brain. Biochem. Pharmacol. 36:747-755; 1987.
72. Schmidt, C. J.; Taylor, V. L. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur. J. Pharmacol. 156:121-131; 1988.
73. Schmidt, C. J.; Wu, L.; Lovenberg, W. Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue. Eur. J. Pharmacol. 124:175-178; 1986.
74. Shoaib, M.; Baumann, M. H.; Rothman, R. B.; Goldberg, S. R.; Schindler, C. W. Behavioural and neurochemical studies of a phenteramine and fenfluramine drug mixture in rats. Abstr. Soc. Neurosci. 20:1287; 1994.
75. Shulgin, A.; Sulgin, A. PIHKAL. Berkeley, CA: Transform Press; 1991.
76. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain. Res. 253:185-193; 1982.
77. 3H]-monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol. 36:2297-2303; 1987.
78. Stone, D. M.; Stahl, D. C.; Hanson, G. R.; Gibb, J. W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128:41-48; 1986.
79. Tessel, R. E.; Woods, J. H. Fenfluramine and N-ethyl amphetamine: Comparison of the reinforcing and rate-decreasing action in the rhesus monkey. Psychopharmacologia 43:503-505; 1975.
80. Van der Kooy, D. Place conditioning: A simple and effective method for assessing the motivational properties of drugs. In: Bozarth, M. A., ed. Methods of assessing the reinforcing properties of abused drugs. New York: Springer-Verlag; 1987:229-240.
81. Westphalen, R. I.; Dodd, P. R. The regeneration of D,L-fenfluramine-destroyed serotonergic nerve terminals. Eur. J. Pharmacol. 238:399-402; 1993.
82. Yamamoto, B. K.; Pehek, E. A. A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res. 506:236-242; 1990.
83. Yamamoto, B. K.; Spanos L. J. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol. 148:195-203; 1988.
84. Zaczek, R.; Battaglia, G.; Culp, S.; Appel, N. M.; Contrera, J. F.; De Souza, E. B. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetics, dose response, regional specificity and time course data. J. Pharmacol. Exp. Ther. 253:104-112; 1990.